Index | Ligand Name | Structure | PDB code | Compound Potency nM |
1 | 31o | Crystal structure of BRD2(BD2) mutant with ligand ME bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1, 4]BENZODIAZEPIN-4-YL]PROPANOATE) | 4qev | 22 |
2 | 73b | C-Terminal bromodomain of Human BRD2 with I-BET726 (GSK1324726A) | 4uyg | 25 |
3 | 73b | N-Terminal bromodomain of Human BRD2 with I-BET726 (GSK1324726A) | 4uyf | 25 |
4 | wsh | Crystal Structure of the First Bromodomain of Human Brd2 with the inhibitor GW841819X | 2ydw | 46 |
5 | 5p4 | Crystal structure of the second bromodomain of human BRD2 in complex with a tetrahydroquinoline inhibitor | 5ek9 | 47 |
6 | eam | Crystal Structure of the First Bromodomain of Human Brd2 with the inhibitor GSK525762 (IBET) | 2yek | 61.3 |
7 | 5gd | X-ray crystal structure of human BRD2(BD2) in complex with RVX297 to 1.55 A resolution | 5dw1 | 80 |
8 | 31p | Crystal structure of BRD2(BD2) mutant with ligand ET bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1, 4]BENZODIAZEPIN-4-YL]BUTANOATE) | 4qew | 86 |
9 | 1k0 | X-ray crystal structure of bromodomain 2 of human brd2 in complex with rvx208 to 1.08 A resolution | 4j1p | 90 |
10 | 1k0 | Crystal Structure of the second bromodomain of human BRD2 in complex with a quinazolinone ligand (RVX-OH) | 4mr5 | 251 |
11 | 1k0 | Crystal Structure of the second bromodomain of human BRD2 in complex with a quinazolinone ligand (RVX-208) | 4mr6 | 251 |
12 | 9s3 | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-((2R,4S)-2-methyl-4-(phenylamino)-6-(4-(piperidin-1-ylmethyl)phenyl)-3,4-dihydroquinolin-1(2H)-yl)ethanone | 4uyh | 500 |
13 | 1gh | N-Terminal Bromodomain of Human BRD2 With IBET-151 | 4alg | 500 |
14 | p9m | N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-cyclopentyl-5-(3,5- dimethyl-1,2-oxazol-4-yl)-2-methylbenzene-1-sulfonamide | 4a9m | 500 |
15 | s5b | N-Terminal Bromodomain of Human BRD2 With tbutyl-phenyl-amino- dimethyl-oxazolyl-quinoline-carboxylic acid | 4akn | 790 |